A Chicago-based pharmaceutical giant recently urged a federal court to block Colorado’s contract pharmacy access law—marking the first drug manufacturer [...] …
Blog Posts
A U.K.-based drugmaker recently asked a federal court to strike down Nebraska’s contract pharmacy access law, making it the latest [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: Optimize NDC selection by evaluating utilization, not just 340B accumulations.
When selecting a preferred National Drug
Vermont and Oregon yesterday became the latest states to enact 340B contract pharmacy access laws, with Vermont’s new statute also [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
AI is everywhere—chatbots, smart assistants, predictive tools. But in 340B? The line between what’s useful and what’s just marketing is getting blurrier by the day.
We’ve seen AI do
…
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maxor, a leading integrated pharmacy services and 340B solutions provider first established nearly 100 years ago in a small Texas [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: Align charge capture and 340B strategy to unlock long-term sustainability.
In today’s margin-pressured environment, 340B savings